Some great news broke recently for the worldwide treatment of COVID-19: the Medicines Patent Pool, a UN-backed non-profit organization, of which WIPO is a board member, agreed to work with Pfizer and Merck Sharp & Dohme (MSD), for the licensing of anti-viral pills - MSD's molnupiravir and Pfizer's PF-07321332 - in nearly 100 low- and middle-income countries.
展开▼
